CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for BIO-TECHNE Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

BIO-TECHNE Corp
614 MCKINLEY PL N E
Phone: (612) 379-8854p:612 379-8854 MINNEAPOLIS, MN  55413  United States Ticker: TECHTECH

Business Summary
Bio-Techne Corporation is a global life sciences company. The Company is engaged in providing tools and bioactive reagents for the research and clinical diagnostic communities. It operates through two segments: Protein Sciences and Diagnostics and Genomics. Its Protein Sciences segment develops and manufactures biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. This segment also includes proteomic analytical tools, both manual and automated, that offer researchers and pharmaceutical manufacturers efficient and streamlined options for automated western blot and multiplexed ELISA workflow. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/20236/30/2023YesYes--Yes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
CFO DEAN HARRIMAN .HARRIMAN
Independent Chairman of the Board Robert V.Baumgartner 67 11/2/2012 8/12/2003
Chief Executive Officer, Chief Operating Officer, Director KimKelderman 56 2/1/2024 4/30/2018
9 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Tocris Bioscience Hung Road Bristol United Kingdom
Lunaphore Technologies SA Route de Lully 5C Tolochenaz Switzerland
Tocris Cookson Ltd. Northpoint, Fourth Way Avonmouth Bristol United Kingdom
11 additional Subsidiary records available in full report.

Business Names
Business Name
Advanced Cell Diagnostics, Inc.
Asuragen, Inc.
Atlanta Biologicals, Inc.
19 additional Business Names available in full report.

General Information
Number of Employees: 3,050 (As of 6/30/2023)
Outstanding Shares: 157,191,685 (As of 2/2/2024)
Shareholders: 150,000
Stock Exchange: NASD
Federal Tax Id: 411427402
Fax Number: (612) 656-4400
Email Address: info@rndsystems.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 19, 2024